These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP. Medicine (Baltimore); 1989 Nov; 68(6):336-52. PubMed ID: 2811660 [Abstract] [Full Text] [Related]
13. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Seikaly MG, Brown R, Baum M. Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990 [Abstract] [Full Text] [Related]
14. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH). Roof BS, Piel CF, Gordan GS. Trans Assoc Am Physicians; 1972 Nov; 85():172-80. PubMed ID: 4349621 [No Abstract] [Full Text] [Related]
15. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K. J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380 [Abstract] [Full Text] [Related]
19. Effects of therapy in X-linked hypophosphatemic rickets. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. N Engl J Med; 1991 Dec 26; 325(26):1843-8. PubMed ID: 1660098 [Abstract] [Full Text] [Related]
20. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets. Short E, Morris RC, Sebastian A, Spencer M. J Clin Invest; 1976 Jul 26; 58(1):152-63. PubMed ID: 180058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]